Inventor · New Haven, CT, US

Aaron Michael Ring

41Patents
9h-index
30Co-inventors
71Inventor score

Filing activity: Dec 22, 2011 → Mar 8, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9428567B2 Antagonists of interleukin-2 receptor Human Necessities 39 Active
US10081680B2 Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies Physics 37 Active
US9845345B2 SIRP polypeptide compositions and methods of use Chemistry; Metallurgy 36 Active
US9562087B2 High affinity PD-1 agents and methods of use Chemistry; Metallurgy 34 Active
US9546206B2 High affinity PD-1 agents and methods of use Chemistry; Metallurgy 26 Active
US10150802B2 Superagonists, partial agonists and antagonists of interleukin-2 Chemistry; Metallurgy 16 Active
US10183980B2 Superagonists and antagonists of interleukin-2 Human Necessities 15 Active
US10781256B2 Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies Physics 14 Active
US9944911B2 High affinity Sirp-alpha reagents and methods of using Physics 10 Active
US10774125B2 SIRP-gamma polypeptide compositions and methods of use Chemistry; Metallurgy 9 Active
US10316094B2 Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance Emerging Cross-Sectional Technologies 8 Active
US10611842B2 Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy Chemistry; Metallurgy 7 Active
US10406179B2 Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling Chemistry; Metallurgy 7 Active
US10618976B2 SIRP-α agonist antibody Chemistry; Metallurgy 5 Active
US10800830B2 High affinity PD-1 agents and methods of use Chemistry; Metallurgy 5 Active
US11208481B2 High affinity SIRP-alpha reagents and methods of using Physics 4 Active
US10654905B2 Method of treating graft versus host disease with an interleukin-2 mutein Chemistry; Metallurgy 2 Active
US11850276B2 Interleukin-18 variants and methods of use Emerging Cross-Sectional Technologies 2 Active
US11419897B2 Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling Chemistry; Metallurgy 1 Active
US10889649B2 Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance Chemistry; Metallurgy 1 Active
US11117943B2 Superagonists and antagonists of interleukin-2 Human Necessities 1 Active
US11407801B2 SIRP-gamma polypeptide compositions and treatment of cancer Chemistry; Metallurgy 1 Active
US11384131B2 Superagonists, partial agonists and antagonists of interleukin-2 Chemistry; Metallurgy 1 Active
US10520516B2 Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner Physics 0 Active
US12029778B2 Interleukin-18 mimics and methods of use Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.